Apolipoprotein C3 (ApoC3) regulates triglyceride metabolism and is associated with accelerated atherogenesis and adverse cardiovascular outcomes. However, its role in peripheral artery disease (PAD) remains unclear. We investigated whether Apoc3 deficiency impacts key features of PAD. Vascularization was assessed using an inflammatory periarterial cuff model (21âdays) and a hind limb ischemia model (14âdays) in male and female Apoc3(+/+) and Apoc3(-/-) mice. Neovascularization was also assessed in mice following extracellular matrix (ECM) plug implantation. Isolated human umbilical vein endothelial cells (HUVECs) were co-cultured with ApoC3-stimulated THP-1 monocytes, and tubule formation was assessed. Apoc3-deficient mice demonstrated less neovessel formation around the cuffed femoral artery, with endothelial cell (CD31+) staining reduced by approximately 40% compared to Apoc3(+/+) mice. Twenty-four hours after cuff placement, Apoc3(+/+) vessels exhibited increased expression of angiogenic (Hif1a and Vegf1) and pro-inflammatory (Cd68) markers, while Apoc3-deficient vessels did not. Confirming a role for inflammation in ApoC3-induced angiogenesis, tubulogenesis of HUVECs increased only in the presence of ApoC3 and THP-1 monocytes. Apoc3 deficiency, however, did not affect ischemia-driven angiogenesis, as there were no differences in revascularization compared to Apoc3(+/+) mice, as assessed by the perfusion index (laser Doppler), fibrosis (Picrosirius red staining), or the mRNA expression of apoptotic (Bax), angiogenic (Hif1a and Vegf1), and inflammatory (Ccl2, Il6, and Vcam1) markers in the ischemic hind limb. Neovascularization following ECM plug implantation was also unaffected by Apoc3 deficiency. In conclusion, ApoC3 contributes to pathological, inflammation-driven angiogenesis, highlighting its potential as a therapeutic target for pathological angiogenesis without inhibiting physiological ischemia-driven angiogenesis.
Apolipoprotein C3 Promotes Angiogenesis in an Inflammatory Mouse Model of Peripheral Artery Disease.
阅读:2
作者:Thomas Jordyn M, Bamhare Panashe, Mulangala Jocelyne, Bursill Christina A, Nicholls Stephen J, Di Bartolo Belinda A, Bubb Kristen J
| 期刊: | FASEB Journal | 影响因子: | 4.200 |
| 时间: | 2025 | 起止号: | 2025 Sep 30; 39(18):e71058 |
| doi: | 10.1096/fj.202502155R | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
